Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients.To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19.A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in...